DUBLIN, June 16, 2023 /PRNewswire/ — The “Extended Release Injectable Drugs” report has been added to ResearchAndMarkets.com’s offering. Chronic conditions require drug administration over long periods of time, placing a greater emphasis on self-administration. With the shift away from…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.